# Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fruquintinib-versus-placebo-in-patients-with-refractory-metastatic-colorectal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arvind Dasari,Sara Lonardi,Rocio García‐Carbonero,Elena Élez,Takayuki Yoshino,Alberto Sobrero,James C. Yao,Pilar García‐Alfonso,Judit Kocsis,Antonio Cubillo Gracián,Andrea Sartore‐Bianchi,Taroh Satoh,Violaine Randrian,Jiří Tomášek,Geoff Chong,Andrew Scott Paulson,Toshiki Masuishi,Jeremy Jones,Tibor Csőszi,Chiara Cremolini,François Ghiringhelli,Ardaman Shergill,Howard S. Höchster,John C. Krauss,Ali Bassam,Michel Ducreux,Anneli Elme,Laurence Faugeras,Stefan Kasper,Eric Van Cutsem,Dirk Arnold,Shivani Nanda,Zhao Yang,William R. Schelman,Marek Kania,Josep Tabernero,Cathy Eng |
| Citations | 336 |
| DOI | 10.1016/s0140-6736(23)00772-9 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0140673623007729/pdf |
| OpenAlex ID | https://openalex.org/W4380887702 |
| PMID | 37331369 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Arvind Dasari](https://scholariq.org/researchers/arvind-dasari/)
- [Sara Lonardi](https://scholariq.org/researchers/sara-lonardi/)
- [James C. Yao](https://scholariq.org/researchers/james-c-yao/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.